This publication shows how our « free of hypothesis » approach can describe all the effects which are induced by an ingredient on an ex vivo classic model. It gives for the ingredient a more extensive understanding of the mechanisms of action and some specific insights, which were also predictive as confirmed at the clinical level, and which allowed supporting a complete and original claiming.

This method shows huge advantages :

– It is based on proteins which are in charge of the structure and the metabolic functions in the cells,

– It is untargeted, which allows to have at the same time a complete view on positive and possible toxic effects.

Link to our JOCD publication

Pubmed https://www.ncbi.nlm.nih.gov/pubmed/29797450

 

62, Route Nationale 113

30620 BERNIS

Tel : +33 4 66 04 77 99
Fax : +33 4 66 04 77 97

e-mail :   gskorski@phylogene.com
web :      www.phylogene.com

http://ms.phylogene.com

LinkedIn : https://www.linkedin.com/company/phylogene

Twitter :    https://twitter.com/Phylogene_One

Recent Posts

A description of CIDP’s innovations at NYSCC Suppliers’ Day 2025

Founded in Mauritius in 2004, providing a full suite of services. These services range from…

Skinobs revamps We Are Testing® with a bold new identity

Skinobs Revamps “We Are Testing” with a bold new identity and website ahead of NYSCC…

We Are Testing® at NYSCC Suppliers’ Day 2025

👉 The Skinobs team will be delighted to welcome you booth 857, to talk with…